{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02893306",
      "OrgStudyIdInfo": {
        "OrgStudyId": "DMT1-MSC"
      },
      "Organization": {
        "OrgFullName": "Universidad del Desarrollo",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "MSC Administration for the Management of Type 1 Diabetic Patients",
      "OfficialTitle": "Phase 2 Study of Intravenous Administration of Allogeneic Mesenchymal Stem Cells in Patients With Type 1 Diabetes Mellitus.",
      "Acronym": "DMT1-MSC"
    },
    "StatusModule": {
      "StatusVerifiedDate": "September 2016",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Active, not recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "March 2012"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "March 2017",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "March 2017",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "August 27, 2016",
      "StudyFirstSubmitQCDate": "September 1, 2016",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "September 8, 2016",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "September 1, 2016",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "September 8, 2016",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Paulette Conget",
        "ResponsiblePartyInvestigatorTitle": "Dr",
        "ResponsiblePartyInvestigatorAffiliation": "Universidad del Desarrollo"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Universidad del Desarrollo",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Clinica Alemana de Santiago",
            "CollaboratorClass": "OTHER"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The purpose of this study is to evaluate whether the administration of multipotent stromal cell also referred as to mesenchymal stem cells (MSCs), modified Type 1 Diabetes progression.",
      "DetailedDescription": "Aim: to evaluate whether a single intravenous administration of allogeneic bone marrow-derived multipotent stromal cell also referred as to mesenchymal stem cells (MSCs), modified endogenous insulin secretion capacity and exogenous insulin requirement in patients with Type 1 Diabetes Mellitus.\n\nParticipants: 10, females or males, 18 years or older, diagnosed with Type 1 Diabetes Mellitus at most 1 year before enrollment, under exogenous insulin treatment, with pancreatic reserve of insulin.\n\nIntervention: intravenous administration of a single dose (2-3 millions/Kg) of allogeneic MSCs.\n\nFollow up: before and 1, 6, 24 months after MSC administration."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Type 1 Diabetes Mellitus"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Type1 Diabetes Mellitus",
          "Multipotent stromal cell",
          "Mesenchymal stem cell",
          "Insulin",
          "Pancreatic reserve",
          "Disease progression"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "10",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "DMT1+MSCs",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "type 1 diabetic patients receiving a single dose of allogeneic ex vivo expanded mesenchymal stem cells",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: MSCs"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "MSCs",
            "InterventionDescription": "origin: bone marrow of healthy donor; manipulation: ex vivo expanded; via: intravenous; vehicle: 5% human recombinant albumin in physiological serum; dose: 2-3 millions/Kg; dosage: single",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "DMT1+MSCs"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "mesenchymal stem cells"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Changes in insulin pancreatic reserve",
            "PrimaryOutcomeDescription": "Levels of insulin secreted after the acute ingestion of a protein rich liquid diet",
            "PrimaryOutcomeTimeFrame": "pre- and 1, 6, 24 months post-intervention"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Changes in insulin requirement",
            "SecondaryOutcomeDescription": "Daily dose of self-administered insulin",
            "SecondaryOutcomeTimeFrame": "pre- and up to 24 months post-intervention"
          }
        ]
      },
      "OtherOutcomeList": {
        "OtherOutcome": [
          {
            "OtherOutcomeMeasure": "Number of patients with grade 3 through grade 5 adverse events (CTCAE v3.0)",
            "OtherOutcomeDescription": "Review of patient clinical records",
            "OtherOutcomeTimeFrame": "up to 24 months post-intervention"
          },
          {
            "OtherOutcomeMeasure": "Number of patients with grade 3 through grade 5 adverse events (CTCAE v3.0)",
            "OtherOutcomeDescription": "Regular communication with patient and his/her physician in order to be informed of eventual complications",
            "OtherOutcomeTimeFrame": "up to 24 months post-intervention"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\ndifferential diagnosis of Type 1 Diabetes\ndiagnosed performed at most 1 year before enrollment\npancreatic reserve of insulin higher than 0.8 nmol/L/h\ngood general health status\ninformed consent of patient\nconsent of treating physician\nproved psychiatric competence to be enrolled in a clinical study\n\nExclusion Criteria:\n\npregnancy\nsignificant comorbidities\nHIV, HBV, HCV, HTLV-1, HLTV-2 or VDRL positive",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Paulette Conget, PhD",
            "OverallOfficialAffiliation": "Universidad del Desarrollo",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "Claudio Mizon, MD",
            "OverallOfficialAffiliation": "Clinica Alemana de Santiago",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Clinica Alemana de Santiago",
            "LocationCity": "Santiago",
            "LocationState": "Region Metropolitana",
            "LocationCountry": "Chile"
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "22644660",
            "ReferenceType": "background",
            "ReferenceCitation": "Ezquer F, Ezquer M, Contador D, Ricca M, Simon V, Conget P. The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment. Stem Cells. 2012 Aug;30(8):1664-74. doi: 10.1002/stem.1132."
          },
          {
            "ReferencePMID": "21304603",
            "ReferenceType": "background",
            "ReferenceCitation": "Ezquer F, Ezquer M, Simon V, Conget P. The antidiabetic effect of MSCs is not impaired by insulin prophylaxis and is not improved by a second dose of cells. PLoS One. 2011 Jan 27;6(1):e16566. doi: 10.1371/journal.pone.0016566."
          },
          {
            "ReferencePMID": "18489988",
            "ReferenceType": "background",
            "ReferenceCitation": "Ezquer FE, Ezquer ME, Parrau DB, Carpio D, Ya√±ez AJ, Conget PA. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. Biol Blood Marrow Transplant. 2008 Jun;14(6):631-40. doi: 10.1016/j.bbmt.2008.01.006. Epub 2008 Apr 14."
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "Yes",
      "IPDSharingDescription": "Data will be publish in a peer review journal"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000003920",
            "ConditionMeshTerm": "Diabetes Mellitus"
          },
          {
            "ConditionMeshId": "D000003922",
            "ConditionMeshTerm": "Diabetes Mellitus, Type 1"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000044882",
            "ConditionAncestorTerm": "Glucose Metabolism Disorders"
          },
          {
            "ConditionAncestorId": "D000008659",
            "ConditionAncestorTerm": "Metabolic Diseases"
          },
          {
            "ConditionAncestorId": "D000004700",
            "ConditionAncestorTerm": "Endocrine System Diseases"
          },
          {
            "ConditionAncestorId": "D000001327",
            "ConditionAncestorTerm": "Autoimmune Diseases"
          },
          {
            "ConditionAncestorId": "D000007154",
            "ConditionAncestorTerm": "Immune System Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M6267",
            "ConditionBrowseLeafName": "Diabetes Mellitus",
            "ConditionBrowseLeafAsFound": "Diabetes Mellitus",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M6269",
            "ConditionBrowseLeafName": "Diabetes Mellitus, Type 1",
            "ConditionBrowseLeafAsFound": "Type 1 Diabetes Mellitus",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M19712",
            "ConditionBrowseLeafName": "Disease Progression",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M10791",
            "ConditionBrowseLeafName": "Metabolic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M24556",
            "ConditionBrowseLeafName": "Glucose Metabolism Disorders",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M7014",
            "ConditionBrowseLeafName": "Endocrine System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M3781",
            "ConditionBrowseLeafName": "Autoimmune Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9352",
            "ConditionBrowseLeafName": "Immune System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC18",
            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC19",
            "ConditionBrowseBranchName": "Gland and Hormone Related Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC20",
            "ConditionBrowseBranchName": "Immune System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M9517",
            "InterventionBrowseLeafName": "Insulin",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M172956",
            "InterventionBrowseLeafName": "Insulin, Globin Zinc",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "Hypo",
            "InterventionBrowseBranchName": "Hypoglycemic Agents"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}